RESULTS & CLINICAL IMPACT - The TRISS Trial
Lars Holst describes the findings and clinical impact of the Transfusion Requirements In Septic Shock (TRISS) trial - comparing the effects and safety of liberal versus restrictive red blood cell transfusion in septic shock patients in the ICU. These results were presented at the Hot Topics Session at LIVES 2014 in Barcelona and simultaneously published in NEJM.
Watch the full presentation below:
<Back to the news list